Who Buys Famotidine from India — 302 Importers Behind a $55.8M Market
India's famotidine import market is served by 302 active buyers who collectively imported $55.8M across 2,750 shipments. MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) leads with a 8.9% market share, followed by J. KNIPPER & COMPANY and MYLAN INSTITUTIONAL INC. The top 5 buyers together control 25.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Famotidine Importers — Ranked by Import Value
MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) is the leading famotidine importer from India, holding a 8.9% share of the $55.8M market across 2,750 shipments from 302 buyers. The top 5 buyers — MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), J. KNIPPER & COMPANY (UNITED STATES), MYLAN INSTITUTIONAL INC (UNITED STATES), M S ASCEND LABORATORIES LLC (UNITED STATES), XXROHXXLTHXXLC (UNITED STATES) — collectively control 25.3% of total import value.
Top Famotidine Buyers & Importers
Ranked by import value · 302 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MYLAN INSTITUTIONAL INC 2898UNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $5.0M | 5 | 8.9% |
| 2 | J. KNIPPER & COMPANYUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $3.2M | 5 | 5.8% |
| 3 | MYLAN INSTITUTIONAL INCUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $2.6M | 5 | 4.6% |
| 4 | M S ASCEND LABORATORIES LLCUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $2.2M | 5 | 3.9% |
| 5 | XXROHXXLTHXXLCUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $1.2M | 5 | 2.2% |
| 6 | GLENMARK THERAPEUTICS INC., USAUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $1.2M | 5 | 2.2% |
| 7 | ASCEND LABORATORIES LLCUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $977.7K | 5 | 1.8% |
| 8 | ASCEND LABORATORIES,LLCUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $906.3K | 5 | 1.6% |
| 9 | DR. REDDYS LABORATORIES, INCUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $890.9K | 5 | 1.6% |
| 10 | TIME-CAP LABS,UNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $828.3K | 5 | 1.5% |
| 11 | CAMBER PHARMACEUTICALS INCUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $774.1K | 5 | 1.4% |
| 12 | MEIJI SEIKA PHARMATECH CO., LTDJAPAN FAMOTIDINE 20MG TABLETS PO NO MM 155 PACK SIZE 55556 NOFAMOTIDINE 20MG TABLETS, PO NO.MM-150, PFAMOTIDINE 10MG TABLETS PO NO MM 154 PACK SIZE 62500 NO | $762.3K | 5 | 1.4% |
| 13 | XXROBXXDO XXARMXXUSAXX INXUNITED STATES FAMOTIDINE TABSFAMOTIDINE TABLETS 20 MG 200'S PACKFAMOTIDINE TABS USP 40MG 100T BT_AP US | $644.2K | 5 | 1.2% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Famotidine — and from which countries?
Flow of Famotidine exports from India: each country's share and the named importers behind the numbers
Famotidine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $46.8M through 546 shipments. This represents a market share of 84.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• MYLAN INSTITUTIONAL INC 2898 - $5.0M (10.6% of country's total business)
• J. KNIPPER & COMPANY - $3.2M (6.9% of country's total business)
• MYLAN INSTITUTIONAL INC - $2.6M (5.5% of country's total business)
• M S ASCEND LABORATORIES LLC - $2.2M (4.6% of country's total business)
• XXROHXXLTHXXLC - $1.2M (2.7% of country's total business)
• Rest of United States's importers - $32.7M (69.8% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $85.8K, indicating premium pricing strategy compared to the market average of $20.3K.
United States is a key market for Famotidine imports, representing 84.0% of total trade value.
2Japan
Japan emerges as the second largest importing country, achieving a total trade value of $2.4M through 12 shipments. This represents a market share of 4.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Japan has a diverse importer base, with their top importers including:
• MEIJI SEIKA PHARMATECH CO., LTD - $762.3K (31.3% of country's total business)
Key Insight: Japan demonstrates strong market positioning with an average shipment value of $202.8K, indicating premium pricing strategy compared to the market average of $20.3K.
Japan is a key market for Famotidine imports, representing 4.4% of total trade value.
3Sri Lanka
Sri Lanka emerges as the third largest importing country, achieving a total trade value of $1.9M through 0 shipments. This represents a market share of 3.5% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $1.9M, indicating premium pricing strategy compared to the market average of $20.3K.
Sri Lanka is a key market for Famotidine imports, representing 3.5% of total trade value.
4Canada
Canada emerges as the fourth largest importing country, achieving a total trade value of $719.2K through 0 shipments. This represents a market share of 1.3% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $719.2K, indicating premium pricing strategy compared to the market average of $20.3K.
Canada is a key market for Famotidine imports, representing 1.3% of total trade value.
5Costa Rica
Costa Rica emerges as the fifth largest importing country, achieving a total trade value of $702.9K through 0 shipments. This represents a market share of 1.3% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Costa Rica demonstrates strong market positioning with an average shipment value of $702.9K, indicating premium pricing strategy compared to the market average of $20.3K.
Costa Rica is a key market for Famotidine imports, representing 1.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Famotidine buyer market intelligence
1Buyer Segment Analysis
The importers of Famotidine from India can be categorized into several key segments:
1. Distributors: These entities purchase Famotidine in bulk to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior typically involves large-volume orders to benefit from economies of scale, with a focus on maintaining a consistent supply chain to meet market demand. In our data, companies such as MYLAN INSTITUTIONAL INC and J. KNIPPER & COMPANY fall into this category, with imports totaling $4.95 million and $3.21 million, respectively.
2. Contract Manufacturers: These organizations procure active pharmaceutical ingredients (APIs) like Famotidine to produce finished dosage forms for other companies under contractual agreements. Their purchasing patterns are aligned with production schedules and client demands, often involving regular, sizable orders to ensure uninterrupted manufacturing processes. Entities such as DR. REDDYS LABORATORIES, INC, which imported $0.89 million worth of Famotidine, exemplify this segment.
3. Pharmaceutical Companies: Firms that develop, produce, and market their own branded or generic medications may import APIs like Famotidine for in-house production. Their procurement strategies are driven by product portfolios, market demand, and regulatory approvals. GLENMARK THERAPEUTICS INC., USA, with imports totaling $1.21 million, represents this category.
Understanding these segments is crucial for tailoring market strategies, forecasting demand, and identifying potential partnerships within the pharmaceutical supply chain.
Country-Specific Import Regulations
TransData Nexus Famotidine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Famotidine from India, the import regulations are as follows:
1. United States:
2. Japan:
3. Sri Lanka:
4. Canada:
5. Costa Rica:
Understanding these regulatory frameworks and timelines is essential for strategic planning and ensuring compliance in the importation of Famotidine into these markets.
Demand Drivers & Market Opportunity
TransData Nexus Famotidine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Famotidine in importing countries is influenced by several key factors:
1. Disease Prevalence: Famotidine is commonly used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The prevalence of these gastrointestinal disorders drives the need for effective treatments, thereby increasing demand for Famotidine.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs and striving for universal health coverage, leading to increased access to essential medicines. For instance, the United States' Affordable Care Act has expanded coverage, potentially increasing the demand for medications like Famotidine.
3. WHO Essential Medicines List Procurement: Famotidine is included in the World Health Organization's Essential Medicines List, which guides procurement decisions in many countries. This inclusion underscores its importance and can lead to increased procurement by national health systems.
4. Tender-Based Purchasing: Many governments and large healthcare organizations procure pharmaceuticals through tender processes to ensure cost-effectiveness and supply security. The presence of 302 buyers across 66 countries, as per our data, indicates a robust market with multiple procurement channels, including tenders.
These factors collectively contribute to the sustained and growing demand for Famotidine in various international markets, presenting significant opportunities for suppliers and manufacturers.
Common Questions — Famotidine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest famotidine buyer importing from India?
Based on import volume and value, MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) leads with $5.0M in imports and a 8.9% market share — the highest of any single famotidine importer. J. KNIPPER & COMPANY (UNITED STATES) and MYLAN INSTITUTIONAL INC (UNITED STATES) are the next largest buyers.
QHow many companies buy famotidine from India?
There are 302 active famotidine buyers importing from India, with a combined market of $55.8M across 2,750 shipments to 66 countries. The top 5 buyers hold 25.3% of total import value, while the remaining 297 buyers handle the other 74.7%.
QWhich countries import the most famotidine from India?
The top importing countries for famotidine from India are United States (84.0%), Japan (4.4%), Sri Lanka (3.5%), Canada (1.3%), Costa Rica (1.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of famotidine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for famotidine from India?
The average import transaction value for famotidine from India is $20.3K, with an average unit price of $39.79 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Famotidine buyer market intelligence
1Buyer Segment Analysis
The importers of Famotidine from India can be categorized into several key segments:
1. Distributors: These entities purchase Famotidine in bulk to supply to various healthcare providers, pharmacies, and retailers. Their buying behavior typically involves large-volume orders to benefit from economies of scale, with a focus on maintaining a consistent supply chain to meet market demand. In our data, companies such as MYLAN INSTITUTIONAL INC and J. KNIPPER & COMPANY fall into this category, with imports totaling $4.95 million and $3.21 million, respectively.
2. Contract Manufacturers: These organizations procure active pharmaceutical ingredients (APIs) like Famotidine to produce finished dosage forms for other companies under contractual agreements. Their purchasing patterns are aligned with production schedules and client demands, often involving regular, sizable orders to ensure uninterrupted manufacturing processes. Entities such as DR. REDDYS LABORATORIES, INC, which imported $0.89 million worth of Famotidine, exemplify this segment.
3. Pharmaceutical Companies: Firms that develop, produce, and market their own branded or generic medications may import APIs like Famotidine for in-house production. Their procurement strategies are driven by product portfolios, market demand, and regulatory approvals. GLENMARK THERAPEUTICS INC., USA, with imports totaling $1.21 million, represents this category.
Understanding these segments is crucial for tailoring market strategies, forecasting demand, and identifying potential partnerships within the pharmaceutical supply chain.
Country-Specific Import Regulations
TransData Nexus Famotidine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Famotidine from India, the import regulations are as follows:
1. United States:
2. Japan:
3. Sri Lanka:
4. Canada:
5. Costa Rica:
Understanding these regulatory frameworks and timelines is essential for strategic planning and ensuring compliance in the importation of Famotidine into these markets.
Demand Drivers & Market Opportunity
TransData Nexus Famotidine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Famotidine in importing countries is influenced by several key factors:
1. Disease Prevalence: Famotidine is commonly used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The prevalence of these gastrointestinal disorders drives the need for effective treatments, thereby increasing demand for Famotidine.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs and striving for universal health coverage, leading to increased access to essential medicines. For instance, the United States' Affordable Care Act has expanded coverage, potentially increasing the demand for medications like Famotidine.
3. WHO Essential Medicines List Procurement: Famotidine is included in the World Health Organization's Essential Medicines List, which guides procurement decisions in many countries. This inclusion underscores its importance and can lead to increased procurement by national health systems.
4. Tender-Based Purchasing: Many governments and large healthcare organizations procure pharmaceuticals through tender processes to ensure cost-effectiveness and supply security. The presence of 302 buyers across 66 countries, as per our data, indicates a robust market with multiple procurement channels, including tenders.
These factors collectively contribute to the sustained and growing demand for Famotidine in various international markets, presenting significant opportunities for suppliers and manufacturers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 302 global importers of Famotidine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,750 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 66 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,750 Verified Shipments
302 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists